Skip to main content

Oculis Holding AG

OCSAW
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001953530

No open-market purchases or sales by Oculis Holding AG insiders were filed in the last 90 days; 8 institutions reported holding it in 13F filings for Q2 2026, worth $1.16M in total; no superinvestor holds it.

Other share classesOCS

Q3 2025 vs. Q2 2025

How the institutions holding Oculis Holding AG changed between Q2 2025 and Q3 2025.

All holders in Q3 2025All holders in Q2 2025

13F holders of OCSAW: Q2 2025 compared with Q3 2025
MeasureQ2 2025Q3 2025Change
Holders1110−1
Shares272.2K262.0K−10.2K (−3.7%)
Value$2.33M$1.74M−$596.8K (−25.6%)

New holders (0)

Institutions that held Oculis Holding AG at the end of Q3 2025 but not at the end of Q2 2025.

None.

Sold out (1)

Institutions that held Oculis Holding AG at the end of Q2 2025 and filed for Q3 2025 without it.

Institutions that sold out of OCSAW in Q3 2025
InstitutionShares, Q2 2025Value, Q2 2025
Omers Administration Corp11,666$95.9K